Canada markets close in 4 hours 31 minutes

ProMIS Neurosciences, Inc. (PMN.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
8.110.00 (0.00%)
As of 03:36PM EDT. Market open.
Full screen
Previous Close8.11
Open8.40
Bid8.11 x 0
Ask8.58 x 0
Day's Range8.11 - 8.40
52 Week Range6.00 - 12.22
Volume700
Avg. Volume3,284
Market Cap58.356M
Beta (5Y Monthly)0.81
PE Ratio (TTM)N/A
EPS (TTM)-0.02
Earnings DateNov 10, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.50
  • GlobeNewswire

    ProMIS Neurosciences appoints accomplished biopharmaceutical leader, Dr. Gail M. Farfel, as Chief Executive Officer

    New CEO brings 25 years’ experience and successful track record in neurological and neuropsychiatric drug developmentTORONTO, Ontario and CAMBRIDGE, Massachusetts , Sept. 13, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN) (TSX: PMN), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, announced today that it has appointed Gail

  • GlobeNewswire

    ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results

    TORONTO, Ontario and CAMBRIDGE, Massachusetts, Aug. 15, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (Nasdaq: PMN) (“ProMIS” or the “Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, today announced its operational and financial results for the three months ended June 30, 2022. “Q2 was another quarter of strong pro

  • Simply Wall St.

    Can ProMIS Neurosciences (TSE:PMN) Afford To Invest In Growth?

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...